Methods for diagnosis and treatment of epithelial-derived cancers
AssigneeUCB Pharma S.A.
InventorJonathan Alexander Terrett
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of a polypeptide (CD27L) for diagnosis of epithelial-related cancers, in particular kidney cancer e.g. renal cell cancer and colorectal cancer, e.g. colon cancers, as well as in methods of treatment of such cancers.
Claims17
A method of screening for and/or diagnosis of epithelial-derived cancer in a subject, and/or monitoring the effectiveness of epithelial-derived cancer therapy, which comprises the step of detecting and/or quantifying in a biological sample obtained from said subject, a CD27L polypeptide which comprises or consists of the amino acid sequence of SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.